These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27245178)

  • 1. Identification of Serum Metabolites Associated With Incident Hypertension in the European Prospective Investigation into Cancer and Nutrition-Potsdam Study.
    Dietrich S; Floegel A; Weikert C; Prehn C; Adamski J; Pischon T; Boeing H; Drogan D
    Hypertension; 2016 Aug; 68(2):471-7. PubMed ID: 27245178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum metabolites and risk of myocardial infarction and ischemic stroke: a targeted metabolomic approach in two German prospective cohorts.
    Floegel A; Kühn T; Sookthai D; Johnson T; Prehn C; Rolle-Kampczyk U; Otto W; Weikert C; Illig T; von Bergen M; Adamski J; Boeing H; Kaaks R; Pischon T
    Eur J Epidemiol; 2018 Jan; 33(1):55-66. PubMed ID: 29181692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of anthropometric markers with serum metabolites using a targeted metabolomics approach: results of the EPIC-potsdam study.
    Bachlechner U; Floegel A; Steffen A; Prehn C; Adamski J; Pischon T; Boeing H
    Nutr Diabetes; 2016 Jun; 6(6):e215. PubMed ID: 27348203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach.
    Floegel A; Stefan N; Yu Z; Mühlenbruch K; Drogan D; Joost HG; Fritsche A; Häring HU; Hrabě de Angelis M; Peters A; Roden M; Prehn C; Wang-Sattler R; Illig T; Schulze MB; Adamski J; Boeing H; Pischon T
    Diabetes; 2013 Feb; 62(2):639-48. PubMed ID: 23043162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Random Survival Forest in practice: a method for modelling complex metabolomics data in time to event analysis.
    Dietrich S; Floegel A; Troll M; Kühn T; Rathmann W; Peters A; Sookthai D; von Bergen M; Kaaks R; Adamski J; Prehn C; Boeing H; Schulze MB; Illig T; Pischon T; Knüppel S; Wang-Sattler R; Drogan D
    Int J Epidemiol; 2016 Oct; 45(5):1406-1420. PubMed ID: 27591264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Circulating Metabolites With Risk of Coronary Heart Disease in a European Population: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium.
    Cavus E; Karakas M; Ojeda FM; Kontto J; Veronesi G; Ferrario MM; Linneberg A; Jørgensen T; Meisinger C; Thorand B; Iacoviello L; Börnigen D; Woodward M; Schnabel R; Costanzo S; Tunstall-Pedoe H; Koenig W; Kuulasmaa K; Salomaa V; Blankenberg S; Zeller T;
    JAMA Cardiol; 2019 Dec; 4(12):1270-1279. PubMed ID: 31664431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of various biomarkers as potential mediators of the association between coffee consumption and incident type 2 diabetes in the EPIC-Potsdam Study.
    Jacobs S; Kröger J; Floegel A; Boeing H; Drogan D; Pischon T; Fritsche A; Prehn C; Adamski J; Isermann B; Weikert C; Schulze MB
    Am J Clin Nutr; 2014 Sep; 100(3):891-900. PubMed ID: 25057154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of metabolite networks from four German population-based studies.
    Iqbal K; Dietrich S; Wittenbecher C; Krumsiek J; Kühn T; Lacruz ME; Kluttig A; Prehn C; Adamski J; von Bergen M; Kaaks R; Schulze MB; Boeing H; Floegel A
    Int J Epidemiol; 2018 Dec; 47(6):2070-2081. PubMed ID: 29982629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation of serum metabolites related to habitual diet: a targeted metabolomic approach in EPIC-Potsdam.
    Floegel A; von Ruesten A; Drogan D; Schulze MB; Prehn C; Adamski J; Pischon T; Boeing H
    Eur J Clin Nutr; 2013 Oct; 67(10):1100-8. PubMed ID: 23942179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The importance of the common cancer registry for the identification of cancer cases in the EPIC Potsdam-study -- results of the first record linkage].
    Bergmann MM; Noethlings U; Eisinger B; Streller B; Quehl A; Walter D; Lahmann PH; Boeing H
    Gesundheitswesen; 2004; 66(8-9):475-81. PubMed ID: 15372347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolites associate with kidney function decline and incident chronic kidney disease in the general population.
    Goek ON; Prehn C; Sekula P; Römisch-Margl W; Döring A; Gieger C; Heier M; Koenig W; Wang-Sattler R; Illig T; Suhre K; Adamski J; Köttgen A; Meisinger C
    Nephrol Dial Transplant; 2013 Aug; 28(8):2131-8. PubMed ID: 23739151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Profile for Prediction of Ischemic Stroke in Chinese Hypertensive Population.
    Guo X; Li Z; Zhou Y; Yu S; Yang H; Zheng L; Liu Y; Sun Y
    J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):1062-1069. PubMed ID: 30642666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. North-south gradients in plasma concentrations of B-vitamins and other components of one-carbon metabolism in Western Europe: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) Study.
    Eussen SJ; Nilsen RM; Midttun Ø; Hustad S; IJssennagger N; Meyer K; Fredriksen Å; Ulvik A; Ueland PM; Brennan P; Johansson M; Bueno-de-Mesquita B; Vineis P; Chuang SC; Boutron-Ruault MC; Dossus L; Perquier F; Overvad K; Teucher B; Grote VA; Trichopoulou A; Adarakis G; Plada M; Sieri S; Tumino R; de Magistris MS; Ros MM; Peeters PH; Redondo ML; Zamora-Ros R; Chirlaque MD; Ardanaz E; Sonestedt E; Ericson U; Schneede J; van Guelpen B; Wark PA; Gallo V; Norat T; Riboli E; Vollset SE
    Br J Nutr; 2013 Jul; 110(2):363-74. PubMed ID: 23228223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective analysis of circulating metabolites and breast cancer in EPIC.
    His M; Viallon V; Dossus L; Gicquiau A; Achaintre D; Scalbert A; Ferrari P; Romieu I; Onland-Moret NC; Weiderpass E; Dahm CC; Overvad K; Olsen A; Tjønneland A; Fournier A; Rothwell JA; Severi G; Kühn T; Fortner RT; Boeing H; Trichopoulou A; Karakatsani A; Martimianaki G; Masala G; Sieri S; Tumino R; Vineis P; Panico S; van Gils CH; Nøst TH; Sandanger TM; Skeie G; Quirós JR; Agudo A; Sánchez MJ; Amiano P; Huerta JM; Ardanaz E; Schmidt JA; Travis RC; Riboli E; Tsilidis KK; Christakoudi S; Gunter MJ; Rinaldi S
    BMC Med; 2019 Sep; 17(1):178. PubMed ID: 31547832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective analysis of circulating metabolites and endometrial cancer risk.
    Dossus L; Kouloura E; Biessy C; Viallon V; Siskos AP; Dimou N; Rinaldi S; Merritt MA; Allen N; Fortner R; Kaaks R; Weiderpass E; Gram IT; Rothwell JA; Lécuyer L; Severi G; Schulze MB; Nøst TH; Crous-Bou M; Sánchez MJ; Amiano P; Colorado-Yohar SM; Gurrea AB; Schmidt JA; Palli D; Agnoli C; Tumino R; Sacerdote C; Mattiello A; Vermeulen R; Heath AK; Christakoudi S; Tsilidis KK; Travis RC; Gunter MJ; Keun HC
    Gynecol Oncol; 2021 Aug; 162(2):475-481. PubMed ID: 34099314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Risk Factors Associated With Blood Metabolite Concentrations and Their Alterations During a 4-Year Period in a Population-Based Cohort.
    Lacruz ME; Kluttig A; Tiller D; Medenwald D; Giegling I; Rujescu D; Prehn C; Adamski J; Frantz S; Greiser KH; Emeny RT; Kastenmüller G; Haerting J
    Circ Cardiovasc Genet; 2016 Dec; 9(6):487-494. PubMed ID: 27784734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between pre-diagnostic circulating lipid metabolites and colorectal cancer risk: a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Harewood R; Rothwell JA; Bešević J; Viallon V; Achaintre D; Gicquiau A; Rinaldi S; Wedekind R; Prehn C; Adamski J; Schmidt JA; Jacobs I; Tjønneland A; Olsen A; Severi G; Kaaks R; Katzke V; Schulze MB; Prada M; Masala G; Agnoli C; Panico S; Sacerdote C; Jakszyn PG; Sánchez MJ; Castilla J; Chirlaque MD; Atxega AA; van Guelpen B; Heath AK; Papier K; Tong TYN; Summers SA; Playdon M; Cross AJ; Keski-Rahkonen P; Chajès V; Murphy N; Gunter MJ
    EBioMedicine; 2024 Mar; 101():105024. PubMed ID: 38412638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Models including plasma levels of sphingomyelins and phosphatidylcholines as diagnostic and prognostic biomarkers of endometrial cancer.
    Knific T; Vouk K; Smrkolj Š; Prehn C; Adamski J; Rižner TL
    J Steroid Biochem Mol Biol; 2018 Apr; 178():312-321. PubMed ID: 29360580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentially modifiable classic risk factors and their impact on incident myocardial infarction: results from the EPIC-Potsdam study.
    Heidemann C; Hoffmann K; Klipstein-Grobusch K; Weikert C; Pischon T; Hense HW; Boeing H
    Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):65-71. PubMed ID: 17301629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Untargeted metabolic profiling identifies altered serum metabolites of type 2 diabetes mellitus in a prospective, nested case control study.
    Drogan D; Dunn WB; Lin W; Buijsse B; Schulze MB; Langenberg C; Brown M; Floegel A; Dietrich S; Rolandsson O; Wedge DC; Goodacre R; Forouhi NG; Sharp SJ; Spranger J; Wareham NJ; Boeing H
    Clin Chem; 2015 Mar; 61(3):487-97. PubMed ID: 25524438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.